How can we help?

WEMIX (WEMIX Mainnet) Trading Competition - 40,000 WEMIX Giveaway!

Dear BitMart Users,

 

WEMIX  (WEMIX)  has been listed on BitMart! To celebrate the listing of WEMIX and thank every user's significant support to the last campaign, we will start the second round of Trading Competition and Participation rewards, worth a total of  40,000 WEMIX (approx. $50,000 ) to all participants!

 

WEMIX-__-__-en__1_.jpg

Period: 02/10/2023 4:00 PM to 03/10/2023 4:00 PM (UTC)

 

I. Trading Competition - 38,500 WEMIX Giveaway!

 

Users will be ranked in terms of the total buying volume (buy+sell) of WEMIX on their BitMart account during the competition period. The top 50 users with the highest buying volume will be rewarded with the corresponding rewards:

 

  • 1st: 5775
  • 2nd:3850
  • 3rd: 3080
  • 4th-10th: 1,456 each
  • 11th-20th: 770 each 
  • 21st - 30th: 385  each 
  • 31st - 50th: 352.65 each

 

II. Participation Rewards: 

 

During the events, all traders will be given 15 WEMIX each only if the WEMIX buying volume is > 200.

 

1500 WEMIX  participation rewards in total. First come, first served.



👉🏻Trade now

 

Note:

  1. Users who use multiple accounts to join will not be qualified for any rewards.
  2. Rewards will be distributed within 15 business days (not including national holidays, and weekends) after the competition concludes.
  3. All trades that we deem to be “wash trades” will not count towards for this competition. BitMart reserves the right to freeze any suspected accounts.
  4. BitMart reserves the right to cancel or amend the competition or competition rules at our sole discretion.



ATTENTION: Cryptocurrency investment is subject to high market risk. Please make your investments cautiously. BitMart will make its best effort to list only high-quality coins, but will not be responsible for your investment losses.

 

Thanks for your support!

 

BitMart Team

Was this article helpful?

0 out of 0 found this helpful

Have more questions? Submit a request

Comments

0 comments

Article is closed for comments.